Case Report
Published on 22 Jan 2024
Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia
in Pediatric Rheumatology
- 2,882 views
- 1 citation